AMGN vs GILD
AMGN and GILD side by side — valuation & fundamentals (public data).
Key statistics
| Metric | AMGNAmgen Inc. | GILDGILEAD SCIENCES, INC. |
|---|---|---|
| Market cap | $203.97B | $178.26B |
| P/E (TTM) | 23.4 | 21.2 |
| P/B | 17.45 | 15.07 |
| P/S | 5.6x | 6.1x |
| Dividend yield | 2.51% | 2.25% |
| Revenue | $38.09B(TTM) | $30.46B(TTM) |
| Revenue growth (YoY) | 10.0% | 2.4% |
| Net income | $8.74B(TTM) | -$3.24B(TTM) |
| Earnings growth (YoY) | 88.5% | 1672.9% |
| EPS, diluted | $16.10(TTM) | $-2.65(TTM) |
| EBIT margin | 24.7% | 34.0% |
| ROE | 66.0% | 71.9% |
| ROIC | 15.1% | 26.7% |
| 1y total return | +36.8% | +24.7% |
Figures from SEC filings · for reference only · not investment advice
Crecimiento de $10,000: AMGN frente a GILD
| Métrica | AMGN | GILD |
|---|---|---|
| Valor final | $32.7K | $23.9K |
| Retorno total | +227.4% | +139.0% |
| CAGR | +12.2% | +8.8% |
| Volatilidad | 25.0% | 25.6% |
| Sharpe | 0.42 | 0.30 |
| Sortino | 0.62 | 0.44 |
| Caída máxima | -24.9% | -30.5% |
Basado en 2600 días de negociación comunes, 2016-05-10 → 2026-09-11 · tasa libre de riesgo 4.07% (bono corto del Tesoro actual, mantenido constante)
A head-to-head total-return backtest over real split- and dividend-adjusted prices: how a one-time $10,000 investment in each stock, held to today, would have grown over their common window — including reinvested dividends. A disclosed historical statistic — NOT a prediction, a guarantee, or investment advice. Past performance does not predict future results.
Related comparisons
Delayed data · Public sources · For reference only · Not investment advice (this page declares no winner)